Loading...
QuidelOrtho Corporation
QDEL•NASDAQ
Healthcare
Medical - Instruments & Supplies
$28.82
$-0.05(-0.17%)
QuidelOrtho Corporation (QDEL) Financial Performance & Statements
Review QuidelOrtho Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-7.17%
↓ 7.17%
Operating Income Growth
-1509.71%
↓ 1509.71%
Net Income Growth
-20216.83%
↓ 20216.83%
Operating Cash Flow Growth
-70.38%
↓ 70.38%
Operating Margin
-3.01%
↓ 3.007%
Gross Margin
55.96%
↑ 55.96%
Net Profit Margin
-12.07%
↓ 12.07%
ROE
-10.82%
↓ 10.82%
ROIC
-1.53%
↓ 1.53%
QuidelOrtho Corporation (QDEL) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for QuidelOrtho Corporation stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $707.80M | $727.10M | $636.30M | $709.70M |
| Cost of Revenue | $381.70M | $374.80M | $412.80M | $431.90M |
| Gross Profit | $326.10M | $352.30M | $223.50M | $277.80M |
| Gross Profit Ratio | $0.46 | $0.48 | $0.35 | $0.39 |
| R&D Expenses | $47.30M | $55.90M | $56.30M | $59.20M |
| SG&A Expenses | $187.50M | $186.40M | $188.20M | $204.70M |
| Operating Expenses | $426.50M | $337.30M | $253.80M | $271.90M |
| Total Costs & Expenses | $808.20M | $712.10M | $666.60M | $703.80M |
| Interest Income | $0.00 | $0.00 | $500000.00 | $900000.00 |
| Interest Expense | $44.70M | $49.90M | $47.80M | $46.30M |
| Depreciation & Amortization | -$4.20M | $113.10M | $116.10M | $114.90M |
| EBITDA | -$100.40M | $127.50M | -$12.80M | -$1.65B |
| EBITDA Ratio | -$0.14 | $0.18 | -$0.02 | -$2.33 |
| Operating Income | -$100.40M | $15.00M | -$30.30M | $5.90M |
| Operating Income Ratio | -$0.14 | $0.02 | -$0.05 | $0.008 |
| Other Income/Expenses (Net) | -$40.50M | -$43.80M | -$45.40M | -$40.90M |
| Income Before Tax | -$140.90M | -$28.80M | -$162.90M | -$1.80B |
| Income Before Tax Ratio | -$0.20 | -$0.04 | -$0.26 | -$2.53 |
| Income Tax Expense | $12.50M | -$8.90M | -$15.20M | -$92.90M |
| Net Income | -$153.40M | -$19.90M | -$147.70M | -$1.71B |
| Net Income Ratio | -$0.22 | -$0.03 | -$0.23 | -$2.40 |
| EPS | -$2.28 | -$0.30 | -$2.20 | -$25.50 |
| Diluted EPS | -$2.28 | -$0.30 | -$2.20 | -$25.50 |
| Weighted Avg Shares Outstanding | $67.30M | $67.30M | $67.10M | $66.90M |
| Weighted Avg Shares Outstanding (Diluted) | $67.30M | $67.30M | $67.10M | $66.90M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan